Literature DB >> 21528879

Microwave-assisted, divergent solution-phase synthesis of 1,3,6-trisubstituted pyrazolo[3,4-d]pyrimidines.

Jing Liu1, Xiaodong Wang.   

Abstract

A concise and highly divergent synthetic route has been developed to rapidly access 1,3,6-trisubstituted pyrazolopyrimidines. The synthesis features a microwave assisted one-pot N1-alkylation/Suzuki-Miyaura reaction as the key step. The sequence of the synthetic scheme can be varied to selectively modify the N1, C3, or C6 position at a late synthetic stage, thereby providing a highly efficient approach to explore the structure-activity relationships of pyrazolopyrimidine derivatives. The scope of these reactions has also been explored.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21528879     DOI: 10.1021/co200039k

Source DB:  PubMed          Journal:  ACS Comb Sci        ISSN: 2156-8944            Impact factor:   3.784


  5 in total

1.  Discovery of Novel Small Molecule Mer Kinase Inhibitors for the Treatment of Pediatric Acute Lymphoblastic Leukemia.

Authors:  Jing Liu; Chao Yang; Catherine Simpson; Deborah Deryckere; Amy Van Deusen; Michael J Miley; Dmitri Kireev; Jacqueline Norris-Drouin; Susan Sather; Debra Hunter; Victoria K Korboukh; Hari S Patel; William P Janzen; Mischa Machius; Gary L Johnson; H Shelton Earp; Douglas K Graham; Stephen V Frye; Xiaodong Wang
Journal:  ACS Med Chem Lett       Date:  2012-02-09       Impact factor: 4.345

2.  Water Solubility Enhancement of Pyrazolo[3,4-d]pyrimidine Derivatives via Miniaturized Polymer-Drug Microarrays.

Authors:  Monica Sanna; Giovanna Sicilia; Ali Alazzo; Nishant Singh; Francesca Musumeci; Silvia Schenone; Keith A Spriggs; Jonathan C Burley; Martin C Garnett; Vincenzo Taresco; Cameron Alexander
Journal:  ACS Med Chem Lett       Date:  2018-01-29       Impact factor: 4.345

3.  UNC1062, a new and potent Mer inhibitor.

Authors:  Jing Liu; Weihe Zhang; Michael A Stashko; Deborah Deryckere; Christopher T Cummings; Debra Hunter; Chao Yang; Chatura N Jayakody; Nancy Cheng; Catherine Simpson; Jacqueline Norris-Drouin; Susan Sather; Dmitri Kireev; William P Janzen; H Shelton Earp; Douglas K Graham; Stephen V Frye; Xiaodong Wang
Journal:  Eur J Med Chem       Date:  2013-04-02       Impact factor: 6.514

4.  UNC2025, a potent and orally bioavailable MER/FLT3 dual inhibitor.

Authors:  Weihe Zhang; Deborah DeRyckere; Debra Hunter; Jing Liu; Michael A Stashko; Katherine A Minson; Christopher T Cummings; Minjung Lee; Trevor G Glaros; Dianne L Newton; Susan Sather; Dehui Zhang; Dmitri Kireev; William P Janzen; H Shelton Earp; Douglas K Graham; Stephen V Frye; Xiaodong Wang
Journal:  J Med Chem       Date:  2014-08-06       Impact factor: 7.446

5.  Unusual rearrangement of imidazo[1,5-a]imidazoles and imidazo[1,2-b]pyrazoles into imidazo[1,5-a]pyrimidines and pyrazolo[1,5-a]pyrimidines.

Authors:  Khadija Gambouz; Mohsine Driowya; Mohammed Loubidi; Zahira Tber; Hassan Allouchi; Saïd El Kazzouli; Mohamed Akssira; Gérald Guillaumet
Journal:  RSC Adv       Date:  2019-09-16       Impact factor: 4.036

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.